[1]
Schroecksnadel, S., Suljkanovic, J., Marth, C., González-Martín, A. and Lorusso, D. 2016. Case 1 – Long-term response to bevacizumab and paclitaxel as second-line therapy in metastatic vaginal carcinoma:  . Cancer Breaking News. 4, 1 (Mar. 2016), 36–40. DOI:https://doi.org/10.19156/cbn.2016.0007.